Inoviv delivers custom, multiplexed LC-MS proteomics panels with absolute quantification and end-to-end support for biomarker discovery and validation. These workflows yield high reproducibility and accuracy—helping pharmaceutical teams accelerate development and reduce risk in clinical programs.